Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
Sinovac Biotech Debt to Equity Ratio: 0.0358 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.0358 |
| December 31, 2023 | 0.0292 |
| June 30, 2023 | 0.025 |
| December 31, 2022 | 0.0018 |
| June 30, 2022 | 0.0019 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0024 |
| June 30, 2021 | 0.0093 |
| December 31, 2017 | 0.2651 |
| June 30, 2017 | 0.2801 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0018
Minimum
Dec 2022
0.0358
Maximum
Jun 2024
0.0151
Average
0.0093
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| CASI Pharmaceuticals Inc | 2.047 |
| Zai Lab Ltd | 0.0998 |
| China SXT Pharmaceuticals Inc | 0.1731 |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.90B |
| Total Liabilities (Quarterly) | 1.390B |
| Shareholders Equity (Quarterly) | 8.649B |
| Current Ratio | 11.39 |
| Net Debt Paydown Yield | -21.04% |